Welcome to our online store!

More Views

LUTEINA 30 sublinqual tablets 50mg Progesterone Лютеина

Product sku: MD1257

Availability: In stock

Only 12 left


Quick Overview

Menstrual disorders



Luteina Indications

The drug is prescribed for the treatment of endogenous progesterone deficiency in the form of menstrual disorders, dysmenorrhea, anovulatory cycles, premenstrual syndrome, dysfunctional uterine bleeding, uterine endometriosis.

With artificial insemination, infertility associated with luteal insufficiency, habitual and threatened miscarriage on a background of progesterone deficiency, insufficiency of the luteal phase of the premenopausal period, secondary amenorrhea, endometrial hypertrophy prevention in women taking estrogens (such as hormone replacement therapy).

Dosage & Adminsitration

Luteina dose in each case must be set individually depending on the indication and therapeutic effect.
When menstrual irregularities and premenstrual syndrome is used for progesterone 50 mg 3-4 times per day sublingually. The treatment lasts for 3-6 consecutive cycles.
For the prevention of endometrial hypertrophy (for hormone replacement therapy) in conjunction with the estrogen most frequently used 50 mg of progesterone 3-4 times a day sublingually. When prolonged drug use discontinuous schemes under the tongue for the last 12-14 days of a 28 day cycle.
When prolonged continuous progesterone schemes used on a daily basis without interruption.
progesterone dose will depend on the dose of estrogen so as to protect the endometrium from the proliferative effect of estrogens.
When the progesterone in the sample taking secondary amenorrhea progesterone at a dose of 50 mg 3-4 times a day sublingually. Menstruation should appear for 7-10 days after treatment.
In the treatment of dysfunctional uterine bleeding is used for progesterone 50 mg 3-4 times a day sublingual from 15 th to 25 th day of the cycle. Treatment should continue 2-3 months in a row.
When habitual and threatened miscarriage, anovulatory and induced cycles used for progesterone 100 mg 3-4 times per day sublingually.


Hypersensitivity to the drug. The period of lactation.

Malignant tumors of breast and reproductive system. Bleeding from the genital tract of unknown etiology.

Severe liver dysfunction. Cholestatic jaundice. Rotor syndrome and Dubin - Johnson.

Thromboembolic disease (deep vein thrombophlebitis, pulmonary embolism). Existing or past thromboembolic disorders in the arteries (angina pectoris, myocardial infarction).

The presence of residues of miscarriage in the uterine cavity.

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.